Home Insider News DocuSign Inc. Sees 5,800 Share Insider Sell From COO Olrich Scott...

DocuSign Inc. [DOCU] Sees 5,800 Share Insider Sell From COO Olrich Scott V.

On Jan. 06, Olrich Scott V. divested U.S. $1,304,252 in shares of DocuSign Inc.. The COO sold 5,800 shares at a price per share of $224.87. The transaction decreased this specific insider’s holdings to 208,746 shares worth around $49.9 million at present.

Piper Sandler took its DocuSign Inc. [DOCU] rating to the equivalent of an Overweight from a Neutral, and the price target to $300 from $225, in a research note dated January 05, 2021. That figure represents around a 20.32% premium from where the company’s shares closed on Thursday. Other analysts also revised their coverage, with Piper Sandler’s analysts upgrading the shares from “a Neutral” rating to “an Overweight” rating in a research note to investors issued in early January. Meanwhile, JP Morgan had lowered its rating on DOCU to “Neutral” from the earlier “an Overweight”, in a research note produced for clients December 09, 2020. In addition, there was a new coverage from Needham on November 18, 2020. The research firm rated DOCU “a Buy”.

The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.


Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Is DocuSign Inc. [NASDAQ:DOCU] a Good Buy Right Now?

It should be noted that DOCU technical indicators for short, intermediate as well as long term progress have placed an overall average of 100% as Buy. The average signal changed from 88% Buy in the last week and compares with 80% Buy in the past month. Data from DocuSign Inc.’s Trend Spotter indicated that the signals were Strongest. The stock current average is 2.98 million shares in the past 20 days and the short term average signal indicates a 100% Buy. In the last 50 days, the average trading volume was 3.81 million shares while the medium term average advocated for 100% Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 4.99 million shares.

DOCU Price Performance

On Wall Street, DocuSign Inc. [NASDAQ:DOCU] finished Thursday’s session up 6.78% at $239.03. The stock went up to $239.79 at the same session while its lowest single day price was $227.90. In the last five days, it saw a rise of about 5.81%, DocuSign Inc. shares gained by almost 7.53% since the beginning of the year. However, the share price has dropped to as low as -17.64% below its one year high. On 01/07/21, the company shares recorded $239.79, the highest single-day price it has got to in the last 52-weeks and a 52-week low was seen on 01/04/21, the same year at $216.50. The company’s shares have inclined by 213.40% in the past year. The 50-day SMA achieved is $224.41 while the 200-day SMA is $184.71. Volume gained to 4.09 million from 2.89 million in the previous session.

DOCU Stock Support And Resistance Levels

On the 24-hour scale, the immediate backing is perceived around 231.36 level, and in case of violation of this particular level, it will cause more drop to 223.68 level. On the upper level, 247.46 is still the key resistance. The stock may increase to the subsequent resistance at 243.25. The Relative Strength Index (RSI) pinned on the 14-day chart is 55.65, implying a neutral technical stance while the MACD stands at -4.96, meaning price will decrease in the next trading period. Percent R indicator moved to 37.92%, implying low price movement. Stochastic %K at 38.47% suggest holding the stock.

What is the short interest in DocuSign Inc.?

Short interest in the DocuSign Inc. stock has surged, increasing by 1.13 million shares to total 7.98 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 9.11 million, data from Yahoo Finance shows. The decrease of -14.16% suggests the stock saw some decreased bullish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 5.07% of the overall float for the stock.

DocuSign Inc.’s Biggest Shareholders: Who Owns DocuSign Inc. [DOCU]?

Filings by The Vanguard Group, Inc. showed that the firm now holds a total of 15,828,618 shares or roughly 8.55% of the outstanding DOCU shares. This means their shares have increased by 295,393 from the 15,828,618 the investor reportedly held in its prior 13-F filing. With the conclusion of the purchase, T. Rowe Price Associates, Inc. updated stake is worth $3,240,787,672. During the last quarter, BlackRock Fund Advisors raised 801,398 of its shares in DocuSign Inc. while Lone Pine Capital LLC bought 4,135,353 shares. The SSgA Funds Management, Inc.’s holdings currently number 3,667,014 shares at $876526356.42. According to the firm’s last 13F report, Franklin Advisers, Inc. shares in the company at filing stood at 2,524,923 shares, roughly $575,379,453.

DOCU Earnings Forecast For The Current Quarter

DocuSign Inc. [DOCU] is expected to report strong earnings results for the quarter ending on Jan 2021. Consensus estimates give the company expected revenues of $407.58M and an earnings per share of $0.22 for Jan 2021. Looking further ahead, the company is expected to report revenue of $419.69M at an EPS of $0.21 for Apr 2021. The estimates represent upside of 32.00% and 50.61% in the company’s revenue and earnings per share, respectively, on a year-on-year basis.

DOCU Earnings Estimates For The Current Year

For the financial year, DocuSign Inc. [NASDAQ:DOCU] is expected to bring in revenue of $1.43B. The returns are nearly $456.03 million higher than the company’s actual revenue recorded in the fiscal year 2020. In terms of EPS for the 2021, estimate put it at 0.74, higher than that of FY20 by $0.43. Estimates put this year’s earnings growth at 138.70%, 51.40% for the next, and at an annual 50.00% over the next 5-year period. As for sales, forecasts are for an increase of 46.80% in the current fiscal year and a further 32.00% over the following year.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

What are analyst thoughts on DocuSign Inc.?

Looking forward to the DocuSign Inc. share price prediction, we can see that analysts, surveyed by FactSet, offer the mean price target for DocuSign Inc. stock at $280.00 within the next 12 months, which represents almost 14.63 per cent growth from its previous closing price of $239.03. The highest analysts’ target for DocuSign Inc. stock projections is $325.00 and the lowest one is $230.00. Still, 18 analysts sharing their consensus rating for DOCU stock in 2021 agree that it is an Overweight.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Sino-Global Shipping (SINO) Is Rising Today: Thanks To A Step Forward In Digital Currency

The provider of shipping and freight logistics integrated solutions Sino-Global Shipping America Ltd. (NASDAQ: SINO) has been experiencing an 11.48% rise in its stock...

Why Genesis Healthcare (GEN) Stock Leapt 14% After-Hours? Here Is An Explanation

Shares of medical care facilities provider Genesis Healthcare, Inc. (NYSE: GEN) rose by 14.07% in after-hours trading on Tuesday following indirectly related news of...

Why Maravai LifeSciences (MRVI) Shares Are Up 20% After-Hour

The stock of global provider of life science reagents and services Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI) surged by 19.94% in trading after...

Iridex Corporation (IRIX) Shares Rose 26.27% After-Hour, Thanks To A Strategic Alliance

Iridex Corporation (NASDAQ: IRIX) saw its shares’ price climbing 26.27% in after-hours trading on Tuesday following news of a strategic collaboration with a Japanese...

Inpixon (INPX) Building its Reputation in the market

Inpixon recently got a huge amount of recognition from various firms. INPX company was commended by Gartner and by IoT Sensor company. These recognitions resulted in an overall good impression of the company. This news gave a huge boost to the company and as a result, the company will be looking forward to attracting more investors.

How Come Ovid Therapeutics Is On The Rise Today?

Price of the biopharmaceutical company Ovid Therapeutics Inc. (NASDAQ: OVID) is on an uptick in early trades today. The stock was at a rise...

Moonpay Integrates NEM (XEM) into its global payment solution

NEM is part of the biggest exchange trading competition. NEM (XEM) has established itself as a renowned crypto asset in the market over the years....

Why The KemPharm (KMPH) Stock Has Been Rising More Than 50% In Early Trades?

The specialty pharmaceutical company KemPharm, Inc. (NASDAQ: KMPH) has been seeing its shares skyrocketing in early trades today. As of 10:46 a.m. EST, the...

Related News

Insider Selling Report: Nu Skin Enterprises Inc. [NUS]’s Pres, Napierski Ryan S, Sells 4,844 Shares

On Jan. 07, Napierski Ryan S divested U.S. $286,038 in shares of Nu Skin Enterprises Inc.. The Pres sold 4,844 shares at a price...

Insider Alert: Harmonic Inc. [HLIT]’s SVP, Video R, D, Haltmayer Neven, Makes A $117,240 Sell

On Jan. 06, Haltmayer Neven divested U.S. $117,240 in shares of Harmonic Inc.. The SVP, Video R, D sold 15,632 shares at a price...

ACM Research Inc. [ACMR] Sees 2,000 Share Insider Sell From Dir Liu Tracy

On Jan. 06, Liu Tracy divested U.S. $200,000 in shares of ACM Research Inc.. The Dir sold 2,000 shares at a price per share...

Insider Selling: MasTec Inc. [MTZ] CFO Sells 30,027 Shares Worth $2,404,436

On Jan. 07, Pita George divested U.S. $2,404,436 in shares of MasTec Inc.. The CFO sold 30,027 shares at a price per share of...

Cigna Corporation [CI] Insider Just Sold 8,972 Shares. Should You?

On Jan. 06, Miller Steven B divested U.S. $1,884,120 in shares of Cigna Corporation. The EVP, Chief Clinical Officer sold 8,972 shares at a...


Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.